JP Morgan Maintains Overweight on PACS Group, Raises Price Target to $58
Benzinga Newsdesk 1 month ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Benjamin Rossi maintains PACS Group (NYSE:PACS) with a Overweight and raises the price target from $47 to $58.
JP Morgan analyst Benjamin Rossi maintains PACS Group (NYSE:PACS) with a Overweight and raises the price target from $47 to $58.